Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2003

View Archived Issues

Central role identified for ghrelin in energy homeostasis

New porphyrin photosensitizers discovered by French team

Juvantia reports alpha2B-adrenoceptor antagonists and their use

Protein aggregation-inhibitory agents for use in dementia therapy

Novartis claims new CCR3 antagonists for asthma and other respiratory disorders

Italian researchers prepare and test antitumor gold complexes

Novel adenosine agonists for cardiovascular and other disorders covered by Bayer patent

New antiangiogenic bisphosphonates: preparation and uses

Merck presents imidazole-based cannabinoid CB1 antagonists with utility in obesity

Development highlights during 2002 at Pliva

Bisphosphonate has antitumor and apoptosis-inducing effects in hematopoietic tumor cells

New factor Xa inhibitors in early development at Bayer

Columbia and Quintiles establish Striant commercialization agreement

PolyHeme trial cleared to begin in severely injured trauma patients

Zoloft contraindication announced

Lundbeck acquires Synaptic

Ezetrol completes Europe's mutual recognition procedure

Unigene files NDA for Fortical

New indication for Arava recommended for approval

GlaxoSmithKline and Shionogi to copromote Valtrex and Zovirax in Japan

NIH licensing opportunity: anti-HIV agents targeting NCp7

Tecastemizole exerts antiinflammatory effects in nasal epithelial cells

Airways hyperresponsiveness in experimental asthma reduced by liposome-encapsulated budesonide

Specific, small-molecule inhibitor of IgE responses characterized at AAAAI meeting

NW-1029 possesses potent and long-lasting antinociceptive effects in inflammatory, neuropathic pain

Mechanism underlying antitumor/antiangiogenic effects of Panzem

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026